Skip to main content

Table 2 Patient and treatment characteristics

From: Dosing practice of low molecular weight heparins and its efficacy and safety in cardiovascular inpatients: a retrospective study in a Chinese teaching hospital

Patient characteristics Data
Age, y 63.8 ± 11.4
 ≥75 years, n (%) 65 (20.8)
Female, n (%) 77 (24.7)
Body mass index 23.8 ± 3.2
Weight, kg 66.8 ± 10.9
Diagnosis, n (%)  
 ST-segment elevation myocardial infarction 53 (17.0)
Unstable angina/Non ST-segment elevation Myocardial infarction 183 (58.6)
 Atrial fibrillation 67 (21.5)
 Deep vein thrombosis 9 (2.9)
Concurrent medical conditions, n (%)  
 Hypertension 194 (62.2)
 Diabetes mellitus 69 (22.1)
Severe renal insufficient, n (%) 7 (2.2)
Creatinine clearance, ml/min 83.1 ± 27.8
Treatment variables, n (%)  
 Cardiac catheterization 26 (8.3)
 Percutaneous coronary intervention 195 (62.5)
 Radiofrequency catheter ablation 44 (14.1)
Length of hospital stay, d 8.9 ± 5.8